Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma
2008

Identifying Tumor Suppressor Genes in Kidney Cancer

Sample size: 127 publication Evidence: moderate

Author Information

Author(s): Morris M R, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Teh B T, Latif F, Maher E R

Primary Institution: University of Birmingham

Hypothesis

A different repertoire of tumor suppressor genes might undergo epigenetic inactivation in renal cell carcinoma compared to other tumor types.

Conclusion

The study identified both known and novel candidate tumor suppressor genes that are epigenetically inactivated in renal cell carcinoma, suggesting a valid strategy for their identification.

Supporting Evidence

  • Re-expression of CXCL16 reduced growth of an RCC cell line in vitro.
  • Promoter region hypermethylation was found in several candidate tumor suppressor genes.
  • Functional epigenomic screens have been successful in identifying epigenetically inactivated tumor suppressor genes in various cancers.

Takeaway

Researchers looked at kidney cancer cells to find genes that are turned off by a process called methylation, which can help us understand the disease better.

Methodology

The study involved gene expression profiling of RCC cell lines treated with a demethylating agent and subsequent analysis of gene expression and methylation status.

Potential Biases

Potential bias in sample selection and the limited number of cell lines analyzed.

Limitations

The study primarily focused on a limited number of RCC cell lines and may not represent all RCC subtypes.

Participant Demographics

Patients with primary renal cell carcinoma and non-cancer-related kidneys.

Statistical Information

P-Value

0.014

Statistical Significance

p=0.014

Digital Object Identifier (DOI)

10.1038/sj.bjc.6604180

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication